Man Wo Tsang

595 total citations
7 papers, 415 citations indexed

About

Man Wo Tsang is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Man Wo Tsang has authored 7 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Man Wo Tsang's work include Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers), Diabetes Treatment and Management (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Man Wo Tsang is often cited by papers focused on Hyperglycemia and glycemic control in critically ill and hospitalized patients (2 papers), Diabetes Treatment and Management (2 papers) and Metabolism, Diabetes, and Cancer (2 papers). Man Wo Tsang collaborates with scholars based in Hong Kong, China and Philippines. Man Wo Tsang's co-authors include Frances Kam Yuet Wong, Moon Fai Chan, Wan Keung Wong, Grace Kam, Chi Wai Chan, Karen S.L. Lam, Jian Xu, Sidney Tam, Sau Cheung Tiu and Shing Chung Siu and has published in prestigious journals such as Diabetes Care, Journal of Advanced Nursing and European Journal of Human Genetics.

In The Last Decade

Man Wo Tsang

7 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Man Wo Tsang Hong Kong 6 213 178 116 83 67 7 415
Alexander Risse Germany 11 290 1.4× 170 1.0× 131 1.1× 101 1.2× 85 1.3× 36 453
Ferdinando Campitiello Italy 11 136 0.6× 164 0.9× 279 2.4× 69 0.8× 12 0.2× 29 457
O M Gibby United Kingdom 10 226 1.1× 119 0.7× 94 0.8× 91 1.1× 45 0.7× 16 371
Raphael Yaakov United States 11 144 0.7× 197 1.1× 112 1.0× 102 1.2× 3 0.0× 19 331
Nasibeh Vatankhah Iran 8 220 1.0× 116 0.7× 37 0.3× 90 1.1× 9 0.1× 16 345
Babak Hajhosseini United States 12 91 0.4× 95 0.5× 194 1.7× 109 1.3× 5 0.1× 23 628
Kristina Heyer Germany 14 119 0.6× 296 1.7× 421 3.6× 214 2.6× 2 0.0× 40 720
Connie Harris Canada 12 80 0.4× 217 1.2× 186 1.6× 155 1.9× 2 0.0× 16 465
Ya Jiang China 10 74 0.3× 60 0.3× 48 0.4× 28 0.3× 13 0.2× 38 321
Emma Mi United Kingdom 10 18 0.1× 54 0.3× 73 0.6× 6 0.1× 19 0.3× 20 387

Countries citing papers authored by Man Wo Tsang

Since Specialization
Citations

This map shows the geographic impact of Man Wo Tsang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Man Wo Tsang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Man Wo Tsang more than expected).

Fields of papers citing papers by Man Wo Tsang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Man Wo Tsang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Man Wo Tsang. The network helps show where Man Wo Tsang may publish in the future.

Co-authorship network of co-authors of Man Wo Tsang

This figure shows the co-authorship network connecting the top 25 collaborators of Man Wo Tsang. A scholar is included among the top collaborators of Man Wo Tsang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Man Wo Tsang. Man Wo Tsang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Pinzon, Rizaldy Taslim, Natalie Schellack, Man Wo Tsang, et al.. (2023). Clinical Recommendations for the use of Neurotropic B vitamins (B1, B6, and B12) for the Management of Peripheral Neuropathy: Consensus from a Multidisciplinary Expert Panel.. PubMed. 71(7). 11–12. 2 indexed citations
2.
Deerochanawong, Chaicharn, et al.. (2017). Optimizing Glycemic Control Through Titration of Insulin Glargine 100 U/mL: A Review of Current and Future Approaches with a Focus on Asian Populations. Diabetes Therapy. 8(6). 1197–1214. 7 indexed citations
3.
Lam, Karen S.L., Chun Chung Chow, K. C. B. Tan, et al.. (2016). Practical considerations for the use of sodium–glucose co-transporter type 2 inhibitors in treating hyperglycemia in type 2 diabetes. Current Medical Research and Opinion. 32(6). 1097–1108. 14 indexed citations
4.
Wong, Frances Kam Yuet, et al.. (2005). Nurse follow‐up of patients with diabetes: randomized controlled trial. Journal of Advanced Nursing. 50(4). 391–402. 90 indexed citations
5.
Xu, Jian, Vivian Chan, Nelson M.S. Wat, et al.. (2004). Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients. European Journal of Human Genetics. 13(4). 422–427. 81 indexed citations
6.
Tsang, Man Wo, et al.. (2004). The use of recombinant human epidermal growth factor (rhEGF) in a gentleman with drug-induced Steven Johnson syndrome. Dermatology Online Journal. 10(1). 25–25. 8 indexed citations
7.
Tsang, Man Wo, et al.. (2003). Human Epidermal Growth Factor Enhances Healing of Diabetic Foot Ulcers. Diabetes Care. 26(6). 1856–1861. 213 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026